Related Experiment Video
Updated: Nov 1, 2025

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
Bone mineral density in spanish children at the diagnosis of inflammatory bowel disease
Etna Masip1, Ester Donat2, Begoña Polo Miquel2
1Pediatric Gastroenterology and Hepatology Unit, University Hospital La Fe, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain. masip_etn@gva.es.
Insights
Pediatric patients with inflammatory bowel disease (IBD) often have low bone mineral density (BMD) at diagnosis. Lower weight and height are significant risk factors for reduced BMD in these children.
Area of Science:
- Pediatrics
- Gastroenterology
- Endocrinology
Background:
- The association between inflammatory bowel disease (IBD) and low bone mineral density (BMD) is established.
- Previous research indicates potential bone density issues even at disease onset.
Purpose of the Study:
- To assess bone mineral density (BMD) in Spanish pediatric patients diagnosed with IBD.
- To identify potential risk factors for low BMD in this cohort at the time of diagnosis.
Main Methods:
- A retrospective review of medical records for pediatric IBD patients diagnosed within the last 10 years.
- Bone mineral density (BMD) was measured at diagnosis and expressed as Z-scores.
Main Results:
- 57 pediatric IBD patients were analyzed; 5% presented with low BMD (Z-score ≤ -2 SD).
- No significant differences in BMD were observed between Crohn's disease and Ulcerative Colitis.
- A significant association was found between lower BMD Z-scores and lower weight and height Z-scores (p<0.05).
Conclusions:
- Suboptimal bone density is prevalent at diagnosis in Spanish pediatric IBD patients.
- Low weight and height at diagnosis are identified as risk factors for diminished bone density.
- These findings underscore the importance of monitoring bone health in pediatric IBD from the point of diagnosis.
Abstract:
The association between low bone mineral density (BMD) and inflammatory bowel disease (IBD) is already known. Our study, performed in Spanish pediatric IBD patients at diagnosis onset, shows that low BMD already existed at the beginning of the disease. Low weight and height are also associated with low BMD and have to be considered as risk factors.
Introduction:
Inflammatory bowel disease (IBD) has been reported to be associated, even at disease onset, with low bone mass. The aim of this study was to know the bone mineral density (BMD) status in the IBD pediatric population of group of Spanish children, at the time of diagnosis.
Material And Methods:
Retrospective review of patients' records from pediatric IBD patients diagnosed in our unit in the last 10 years. BMD was measured at the time of diagnosis and was expressed by Z-score.
Results:
Fifty-seven patients were included. Sixty-one percent were male and 47.4% had Crohn's disease (CD). Average age was 11.18 (SD 2.24) years old. Median BMD Z-score was - 0.30 (interquartile range: - 1.10 to + 0.10). Low BMD, defined as Z-score ≤ - 2SD, was present in 5% of patients, but there was no single patient with osteoporosis. There were no differences in BMD between Ulcerative Colitis (UC) and CD. Statistical differences appeared between healthy Spanish pediatric population and our IBD cohort, these having lower BMD for the same age and gender. A linear regression analysis showed a significant association between BMD Z-score and patient´s weight and height Z-score with a p values of 0.001 and 0.048, respectively.
Conclusions:
Suboptimal bone density is present at diagnosis in Spanish pediatric patients with IBD. There is no difference in BMD between patients with CD and UC. Lower weight and height are associated with a lower BMD; thus these data at IBD diagnosis should be considered as a risk factor for bone disease in the pediatric population.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

